arginine has been researched along with ATLL in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, T; Iha, H; Manachai, N; Morishita, K; Nakahata, S; Ono, M; Shanab, O; Shimoda, K; Shimosaki, S | 1 |
| de Oliveira, MP; Franchini, G; Johnson, JM; Mulloy, JC; Takemoto, S; Trovato, R | 1 |
| Beck, WT; Kim, R | 1 |
| Adair, S; Camitta, BM; Casper, JT; Civin, CI; Graham, M; Kiefer, G; Lauer, SJ; Leventhal, BG; Mahoney, DH; Shuster, JJ | 1 |
| Burdach, S; Göbel, U; Harms, DO; Janka-Schaub, G; Kapaun, P; Körholz, D; Kramm, C; Niehues, T | 1 |
| Amylon, M; Barredo, JC; Borowitz, M; Camitta, BM; Kurtzberg, J; Laver, JH; Link, MP; Murphy, SB; Pullen, J; Ravindranath, Y; Schwenn, M; Shuster, J | 1 |
6 other study(ies) available for arginine and ATLL
| Article | Year |
|---|---|
Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Arginine; Carboxylic Ester Hydrolases; Cell Line, Tumor; HSP90 Heat-Shock Proteins; Humans; Leukemia-Lymphoma, Adult T-Cell; Methylation; Phosphorylation; Protein Binding; Protein-Arginine N-Methyltransferases; Proteolysis; RNA Interference; RNA, Small Interfering; Tumor Suppressor Proteins | 2020 |
A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability.
Topics: Adult; Alleles; Amino Acid Sequence; Amino Acid Substitution; Arginine; Binding Sites; Carrier State; Cysteine Endopeptidases; Human T-lymphotropic virus 1; Humans; Leucine Zippers; Leukemia-Lymphoma, Adult T-Cell; Lysine; Molecular Sequence Data; Multienzyme Complexes; Oncogene Proteins, Viral; Paraparesis, Tropical Spastic; Proteasome Endopeptidase Complex; Transcription Factors; Ubiquitins; Viral Regulatory and Accessory Proteins | 1999 |
Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Topics: Base Sequence; Dactinomycin; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance; Genes, jun; Humans; Leukemia-Lymphoma, Adult T-Cell; Molecular Sequence Data; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; RNA, Messenger; Teniposide; Time Factors; Tumor Cells, Cultured | 1994 |
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Hydrocortisone; Infant; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Treatment Failure | 1993 |
A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies.
Topics: Adolescent; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Child; Child, Preschool; Clonal Deletion; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Germany; Humans; Immunophenotyping; Infant; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Neoplastic Stem Cells; Prednisolone; Remission Induction; Risk; T-Lymphocyte Subsets; Teniposide; Thioguanine; Treatment Outcome; Vincristine | 1999 |
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Leukemic Infiltration; Male; Methotrexate; Podophyllotoxin; Prognosis; Remission Induction; Risk; Teniposide; Treatment Outcome | 2000 |